The Federal Food and Drug Administartion (FDA) conditionally approved Varenzin-CA1 (molidustat oral suspension) for cats with nonregenerative anemia due to chronic kidney failure. This type of anemia is secondary to renal failure. Chronic kidney disease is a common ailment of senior cats.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to CatWatch
Get the next year of CatWatch for just $20. And access all of our back issues and online content free of charge.
Subscribe today and save 50% off the regular rate!
